South Korea · Delayed Price · Currency is KRW Prestige Biologics Statistics
Total Valuation
KOSDAQ:334970 has a market cap or net worth of KRW 109.48 billion. The enterprise value is 203.84 billion.
| Market Cap | 109.48B |
| Enterprise Value | 203.84B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
KOSDAQ:334970 has 77.75 million shares outstanding. The number of shares has increased by 5.54% in one year.
| Current Share Class | 77.75M |
| Shares Outstanding | 77.75M |
| Shares Change (YoY) | +5.54% |
| Shares Change (QoQ) | -0.15% |
| Owned by Insiders (%) | 20.34% |
| Owned by Institutions (%) | 0.07% |
| Float | 30.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.11 |
| PB Ratio | 1.21 |
| P/TBV Ratio | 1.23 |
| P/FCF Ratio | 120.18 |
| P/OCF Ratio | 34.18 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.64 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 223.77 |
Financial Position
The company has a current ratio of 0.29, with a Debt / Equity ratio of 1.12.
| Current Ratio | 0.29 |
| Quick Ratio | 0.08 |
| Debt / Equity | 1.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | 111.21 |
| Interest Coverage | -7.13 |
Financial Efficiency
Return on equity (ROE) is -45.40% and return on invested capital (ROIC) is -14.73%.
| Return on Equity (ROE) | -45.40% |
| Return on Assets (ROA) | -11.48% |
| Return on Invested Capital (ROIC) | -14.73% |
| Return on Capital Employed (ROCE) | -43.23% |
| Weighted Average Cost of Capital (WACC) | 6.07% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.10 |
| Inventory Turnover | 1.69 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.86% in the last 52 weeks. The beta is 0.44, so KOSDAQ:334970's price volatility has been lower than the market average.
| Beta (5Y) | 0.44 |
| 52-Week Price Change | -55.86% |
| 50-Day Moving Average | 1,682.38 |
| 200-Day Moving Average | 2,256.57 |
| Relative Strength Index (RSI) | 35.90 |
| Average Volume (20 Days) | 161,584 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KOSDAQ:334970 had revenue of KRW 26.67 billion and -51.22 billion in losses. Loss per share was -658.76.
| Revenue | 26.67B |
| Gross Profit | -19.42B |
| Operating Income | -49.30B |
| Pretax Income | -51.22B |
| Net Income | -51.22B |
| EBITDA | -32.44B |
| EBIT | -49.30B |
| Loss Per Share | -658.76 |
Balance Sheet
The company has 6.94 billion in cash and 101.31 billion in debt, with a net cash position of -94.36 billion or -1,213.64 per share.
| Cash & Cash Equivalents | 6.94B |
| Total Debt | 101.31B |
| Net Cash | -94.36B |
| Net Cash Per Share | -1,213.64 |
| Equity (Book Value) | 90.46B |
| Book Value Per Share | 1,163.38 |
| Working Capital | -107.60B |
Cash Flow
In the last 12 months, operating cash flow was 3.20 billion and capital expenditures -2.29 billion, giving a free cash flow of 910.95 million.
| Operating Cash Flow | 3.20B |
| Capital Expenditures | -2.29B |
| Depreciation & Amortization | 16.87B |
| Net Borrowing | 5.14B |
| Free Cash Flow | 910.95M |
| FCF Per Share | 11.72 |
Margins
Gross margin is -72.82%, with operating and profit margins of -184.89% and -192.09%.
| Gross Margin | -72.82% |
| Operating Margin | -184.89% |
| Pretax Margin | -192.09% |
| Profit Margin | -192.09% |
| EBITDA Margin | -121.64% |
| EBIT Margin | -184.89% |
| FCF Margin | 3.42% |
Dividends & Yields
KOSDAQ:334970 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -5.54% |
| Shareholder Yield | -5.54% |
| Earnings Yield | -46.79% |
| FCF Yield | 0.83% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KOSDAQ:334970 has an Altman Z-Score of -1.77 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.77 |
| Piotroski F-Score | 5 |